Tectonic Therapeutic

Website

Tectonic Therapeutic, Inc.

29 Investors
Biotechnology
WATERTOWN, MA

Tectonic Therapeutic, Inc. is a pioneering biotechnology company based in Watertown, Massachusetts, dedicated to the discovery and development of advanced therapeutic proteins and antibodies. The company primarily focuses on harnessing the potential of G-Protein Coupled Receptors (GPCRs), which are integral to numerous biological processes and disease pathways.

Products & Team

GEODe™ Technology Platform

Biologic MedicinesSeed

The GEODe™ technology platform represents a breakthrough approach in biotechnology that facilitates the targeting of GPCRs, significantly enhancing the development of therapeutic proteins and antibodies. This platform overcomes traditional barriers in drug development, enabling more effective and safer biologics.

Value Proposition

The GEODe™ platform is designed to solve the problem of developing effective treatments for diseases that currently lack adequate therapeutic options, thereby aiming to improve the quality of life for patients suffering from these conditions.

Pain Points

Tectonic Therapeutic addresses the challenge of limited treatment options for various diseases, especially those where traditional therapies have failed to provide effective outcomes.

Proprietary technology specifically targeting GPCRsStreamlined drug development processAbility to modify disease progression
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
WATERTOWN, MA
Primary headquarters

Funding History

Total Raised:
$185.0M
E

Equity Offering

Closed
February 2025
$185.0M
Raised
Progress
100%
Raised
$185.0M
Target
$185.0M
#000123191925000022